184
Views
47
CrossRef citations to date
0
Altmetric
Original Research

Impact of symptomatic hypoglycemia on medication adherence, patient satisfaction with treatment, and glycemic control in patients with type 2 diabetes

, , , , &
Pages 593-601 | Published online: 30 Apr 2014

References

  • WildSRoglicGGreenASicreeRKingHGlobal prevalence of diabetes estimates for the year 2000 and projections for 2030Diabetes Care20042751047105315111519
  • CarlssonACWandellPOsbyUZarrinkoubRWettermarkBLjunggrenGHigh prevalence of diagnosis of diabetes, depression, anxiety, hypertension, asthma and COPD in the total population of Stockholm, Sweden – a challenge for public healthBMC Public Health201313167023866784
  • WirehnABKarlssonHMCarstensenJMEstimating disease prevalence using a population-based administrative healthcare databaseScand J Public Health200735442443117786807
  • HuxleyRBarziFWoodwardMExcess risk of fatal coronary heart disease associated with diabetes in men and women: meta-analysis of 37 prospective cohort studiesBMJ20063327533737816371403
  • StamlerJVaccaroONeatonJDWentworthDDiabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention TrialDiabetes Care19931624344448432214
  • GaedePLund-AndersenHParvingHHPedersenOEffect of a multifactorial intervention on mortality in type 2 diabetesN Engl J Med2008358658059118256393
  • RayKKSeshasaiSRWijesuriyaSEffect of intensive control of glucose on cardiovascular outcomes and death in patients with diabetes mellitus: a meta-analysis of randomised controlled trialsLancet200937396771765177219465231
  • StrattonICullCAdlerAMatthewsDNeilHHolmanRAdditive effects of glycaemia and blood pressure exposure on risk of complications in type 2 diabetes: a prospective observational study (UKPDS 75)Diabetologia20064981761176916736131
  • TurnbullFMAbrairaCAndersonRJIntensive glucose control and macrovascular outcomes in type 2 diabetesDiabetologia200952112288229819655124
  • SkylerJSBergenstalRBonowROIntensive glycemic control and the prevention of cardiovascular events: implications of the ACCORD, ADVANCE, and VA diabetes trials: a position statement of the American Diabetes Association and a scientific statement of the American College of Cardiology Foundation and the American Heart AssociationDiabetes Care200932118719219092168
  • DuckworthWAbrairaCMoritzTGlucose control and vascular complications in veterans with type 2 diabetesN Engl J Med2009360212913919092145
  • GersteinHCMillerMEByingtonRPEffects of intensive glucose lowering in type 2 diabetesN Engl J Med2008358242545255918539917
  • HemmingsenBLundSSGluudCIntensive glycaemic control for patients with type 2 diabetes: systematic review with meta-analysis and trial sequential analysis of randomised clinical trialsBMJ2011343d689822115901
  • CurrieCJPetersJRTynanASurvival as a function of HbA1c in people with type 2 diabetes: a retrospective cohort studyLancet2010375971348148920110121
  • AscheCLaFleurJConnerCA review of diabetes treatment adherence and the association with clinical and economic outcomesClin Ther20113317410921397776
  • GuillausseauPJInfluence of oral antidiabetic drugs compliance on metabolic control in type 2 diabetes. A survey in general practiceDiabetes Metab2003291798112629452
  • PladevallMWilliamsLKPottsLADivineGXiHLafataJEClinical outcomes and adherence to medications measured by claims data in patients with diabetesDiabetes Care200427122800280515562188
  • RheeMKSlocumWZiemerDCPatient adherence improves glycemic controlDiabetes Educ200531224025015797853
  • The Swedish National Board of Health and WelfareNational Guidelines for Diabetes Care2010 Available from: http://www.socialstyrelsen.se/nationellariktlinjerfordiabetesvardenAccessed February 5, 2013
  • Eeg-OlofssonKCederholmJNilssonPMNew aspects of HbA1c as a risk factor for cardiovascular diseases in type 2 diabetes: an observational study from the Swedish National Diabetes Register (NDR)J Intern Med2010268547148220804517
  • EkstromNMiftarajMSvenssonAMGlucose-lowering treatment and clinical results in 163,121 patients with type 2 diabetes: an observational study from the Swedish National Diabetes RegisterDiabetes Obes Metab201214871772622364580
  • BurgeMRSoodVSobhyTARassamAGSchadeDSSulphonylurea-induced hypoglycaemia in type 2 diabetes mellitus: a reviewDiabetes Obes Metab19991419920611228754
  • BelseyJKrishnarajahGGlycaemic control and adverse events in patients with type 2 diabetes treated with metformin + sulphonylurea: a meta-analysisDiabetes Obes Metab200810Suppl 11718435668
  • PetterssonBRosenqvistUDeleskogAJournathGWandellPSelf-reported experience of hypoglycemia among adults with type 2 diabetes mellitus (Exhype)Diabetes Res Clin Pract2011921192521195501
  • VexiauPMavrosPKrishnarajahGLyuRYinDHypoglycaemia in patients with type 2 diabetes treated with a combination of metformin and sulphonylurea therapy in FranceDiabetes Obes Metab200810Suppl 1162418435670
  • Alvarez GuisasolaFTofe PovedanoSKrishnarajahGLyuRMavrosPYinDHypoglycaemic symptoms, treatment satisfaction, adherence and their associations with glycaemic goal in patients with type 2 diabetes mellitus: findings from the Real-Life Effectiveness and Care Patterns of Diabetes Management (RECAP-DM) StudyDiabetes Obes Metab200810Suppl 1253218435671
  • GrantRWDevitaNGSingerDEMeigsJBImproving adherence and reducing medication discrepancies in patients with diabetesAnn Pharmacother2003377–896296912841801
  • GrantRWDevitaNGSingerDEMeigsJBPolypharmacy and medication adherence in patients with type 2 diabetesDiabetes Care20032651408141212716797
  • AtkinsonMJSinhaAHassSLValidation of a general measure of treatment satisfaction, the Treatment Satisfaction Questionnaire for Medication (TSQM), using a national panel study of chronic diseaseHealth Qual Life Outcomes200421214987333
  • DiMatteoMRVariations in patients’ adherence to medical recommendations: a quantitative review of 50 years of researchMed Care200442320020915076819
  • BronMMarynchenkoMYangHYuAPWuEQHypoglycemia, treatment discontinuation, and costs in patients with type 2 diabetes mellitus on oral antidiabetic drugsPostgrad Med2012124112413222314122
  • CryerPEHypoglycemia: still the limiting factor in the glycemic management of diabetesEndocr Pract200814675075618996798
  • DavisSAlonsoMDHypoglycemia as a barrier to glycemic controlJ Diabetes Complications2004181606815019602
  • LevitSToledanoYWainsteinJImproved glycaemic control with reduced hypoglycaemic episodes and without weight gain using long-term modern premixed insulins in type 2 diabetesInt J Clin Pract201165216517121166963
  • NyhlinKTLithnerFNorbergAExperience of being diabeticScand J Caring Sci19871259673453546
  • AlazriMHNealRDThe association between satisfaction with services provided in primary care and outcomes in type 2 diabetes mellitusDiabet Med200320648649012786685
  • DavisREMorrisseyMPetersJRWittrup-JensenKKennedy-MartinTCurrieCJImpact of hypoglycaemia on quality of life and productivity in type 1 and type 2 diabetesCurr Med Res Opin20052191477148316197667
  • CramerJAA systematic review of adherence with medications for diabetesDiabetes Care20042751218122415111553
  • HoPMRumsfeldJSMasoudiFAEffect of medication nonadherence on hospitalization and mortality among patients with diabetes mellitusArch Intern Med2006166171836184117000939
  • SokolMCMcGuiganKAVerbruggeRREpsteinRSImpact of medication adherence on hospitalization risk and healthcare costMed Care200543652153015908846
  • WhiteTJVanderplasAChangEDeziiCMAbramsGDThe costs of nonadherence to oral antihyperglycemic medication in individuals with diabetes mellitus and concomitant diabetes mellitus and cardiovascular disease in a managed care environmentDisease Management and Health Outcomes2004123181188
  • WildHThe economic rationale for adherence in the treatment of type 2 diabetes mellitusAm J Manag Care2012183 SupplS43S4822558941
  • GlasgowREToobertDJRiddleMDonnellyJMitchellDLCalderDDiabetes-specific social learning variables and self-care behaviors among persons with type II diabetesHealth Psychol1989832853032767020
  • JohnsonSBMethodological issues in diabetes research. Measuring adherenceDiabetes Care19921511165816671468298
  • SchmittdielJAUratsuCSKarterAJWhy don’t diabetes patients achieve recommended risk factor targets? Poor adherence versus lack of treatment intensificationJ Gen Intern Med200823558859418317847
  • CryerPEHypoglycemia is the limiting factor in the management of diabetesDiabetes Metab Res Rev1999151424610398545
  • LundkvistJBerneCBolinderBJonssonLThe economic and quality of life impact of hypoglycemiaEur J Health Econ20056319720215761775
  • PatrickDLBurkeLBPowersJHPatient-reported outcomes to support medical product labeling claims: FDA perspectiveValue Health200710S125S13717995471
  • RevickiDHaysRDCellaDSloanJRecommended methods for determining responsiveness and minimally important differences for patient-reported outcomesJ Clin Epidemiol200861210210918177782
  • WillkeRJBurkeLBEricksonPMeasuring treatment impact: a review of patient-reported outcomes and other efficacy endpoints in approved product labelsControl Clin Trials200425653555215588741
  • Barrett-ConnorEWadeSWDoTPTreatment satisfaction and persistence among postmenopausal women on osteoporosis medications: 12-month results from POSSIBLE USOsteoporos Int201223273374121625886
  • AmielSADixonTMannRJamesonKHypoglycaemia in type 2 diabetesDiabet Med200825324525418215172
  • CramerJAMattsonRHPreveyMLScheyerRDOuelletteVLHow often is medication taken as prescribed? A novel assessment techniqueJAMA198926122327332772716163
  • GarberMCNauDPEricksonSRAikensJELawrenceJBThe concordance of self-report with other measures of medication adherence: a summary of the literatureMed Care200442764965215213489